GAIN THERAPEUTICS INC (GANX)

US36269B1052 - Common Stock

3.03  -0.04 (-1.3%)

After market: 3.08 +0.05 (+1.65%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
55.18K140.00K160.00K30.00K40.00K
Operating Expenses
22.31M17.92M13.99M3.51M2.14M
Research and Development
11.38M8.38M7.16M2.26M1.59M
Selling, General, and Administrative Expenses
10.88M9.54M6.83M1.25M560.00K
Operating Income
-22.25M-17.78M-13.83M-3.48M-2.10M
Interest Income/Expense
64.88K280.00K-60.00K-90.00K-90.00K
Income Before Taxes
-22.19M-17.50M-13.89M-3.57M-2.19M
Income Tax
79.28K90.00K0.0010.00K10.00K
Net Income
-22.27M-17.59M-13.89M-3.58M-2.19M
EBITDA
-22.17M-17.72M-13.81M-3.47MN/A
 
Per Share Data
EPS Diluted Total Ops
-1.71-1.48-1.37-0.32-0.19
Non GAAP EPS
-1.78-1.48-1.51N/AN/A
 
Statistics
Profit Margin
-40354.33%-12564.29%-8681.25%-11933.33%-5475.00%
Operating Profit Margin
-40328.25%-12700.00%-8643.75%-11600.00%-5250.00%

All data in USD

Charts